Wang Haoyi
Cited by
Cited by
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering
H Wang, H Yang, CS Shivalila, MM Dawlaty, AW Cheng, F Zhang, ...
cell 153 (4), 910-918, 2013
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering
H Yang, H Wang, CS Shivalila, AW Cheng, L Shi, R Jaenisch
Cell 154 (6), 1370-1379, 2013
Genetic engineering of human pluripotent cells using TALE nucleases
D Hockemeyer, H Wang, S Kiani, CS Lai, Q Gao, JP Cassady, GJ Cost, ...
Nature biotechnology 29 (8), 731-734, 2011
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system
AW Cheng, H Wang, H Yang, L Shi, Y Katz, TW Theunissen, ...
Cell research 23 (10), 1163-1171, 2013
Systematic identification of culture conditions for induction and maintenance of naive human pluripotency
TW Theunissen, BE Powell, H Wang, M Mitalipova, DA Faddah, J Reddy, ...
Cell stem cell 15 (4), 471-487, 2014
Generating genetically modified mice using CRISPR/Cas-mediated genome engineering
H Yang, H Wang, R Jaenisch
Nature protocols 9 (8), 1956-1968, 2014
Molecular criteria for defining the naive human pluripotent state
TW Theunissen, M Friedli, Y He, E Planet, RC O’Neil, S Markoulaki, ...
Cell stem cell 19 (4), 502-515, 2016
Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons
Y Li, H Wang, J Muffat, AW Cheng, DA Orlando, J Lovén, S Kwok, ...
Cell stem cell 13 (4), 446-458, 2013
Functional integration of dopaminergic neurons directly converted from mouse fibroblasts
J Kim, SC Su, H Wang, AW Cheng, JP Cassady, MA Lodato, CJ Lengner, ...
Cell stem cell 9 (5), 413-419, 2011
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
X Liu, Y Zhang, C Cheng, AW Cheng, X Zhang, N Li, C Xia, X Wei, X Liu, ...
Cell research 27 (1), 154-157, 2017
Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease
S Sarkar, B Carroll, Y Buganim, D Maetzel, AHM Ng, JP Cassady, ...
Cell reports 5 (5), 1302-1315, 2013
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
C Dong, L Qu, H Wang, L Wei, Y Dong, S Xiong
Antiviral research 118, 110-117, 2015
Efficient CRISPR/Cas9-mediated genome editing in mice by zygote electroporation of nuclease
W Qin, SL Dion, PM Kutny, Y Zhang, AW Cheng, NL Jillette, A Malhotra, ...
Genetics 200 (2), 423-430, 2015
Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells
D Maetzel, S Sarkar, H Wang, L Abi-Mosleh, P Xu, AW Cheng, Q Gao, ...
Stem cell reports 2 (6), 866-880, 2014
CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells
Y Zhang, X Zhang, C Cheng, W Mu, X Liu, N Li, X Wei, X Liu, C Xia, ...
Frontiers of medicine 11 (4), 554-562, 2017
TALEN-mediated editing of the mouse Y chromosome
H Wang, YC Hu, S Markoulaki, GG Welstead, AW Cheng, CS Shivalila, ...
Nature biotechnology 31 (6), 530-532, 2013
TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors
N Tang, C Cheng, X Zhang, M Qiao, N Li, W Mu, XF Wei, W Han, H Wang
JCI insight 5 (4), 2020
Single-cell analysis reveals that expression of nanog is biallelic and equally variable as that of other pluripotency factors in mouse ESCs
DA Faddah, H Wang, AW Cheng, Y Katz, Y Buganim, R Jaenisch
Cell stem cell 13 (1), 23-29, 2013
Casilio: a versatile CRISPR-Cas9-Pumilio hybrid for gene regulation and genomic labeling
AW Cheng, N Jillette, P Lee, D Plaskon, Y Fujiwara, W Wang, ...
Cell research 26 (2), 254-257, 2016
Bedside back to bench: building bridges between basic and clinical genomic research
TA Manolio, DM Fowler, LM Starita, MA Haendel, DG MacArthur, ...
Cell 169 (1), 6-12, 2017
The system can't perform the operation now. Try again later.
Articles 1–20